Pharma Provisions in TTIP Trade Pact Could Boost Danish Jobs, Exports
This article was originally published in The Pink Sheet Daily
Denmark could benefit markedly from lowering non-tariff trade barriers between Europe and U.S., including the harmonization of pharmaceutical regulations and intellectual property rights processes.
You may also be interested in...
Dutch and Belgian health agencies will undertake a pilot project next year on jointly negotiating prices with pharma companies.
France’s fledgling biotech Dynacure has pulled together a series C funding round to support its ongoing Phase I/II study of an antisense molecule for an ultrarare myopathy.